XML 57 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
In Millions, unless otherwise specified
 3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Cash provided (required) by operating activities of continuing operations:    
Net income $ 70.4 $ 135.0
Discontinued operations 50.1 3.2
Income from continuing operations 120.5 138.2
Adjustments from income from continuing operations to cash provided (required) by operating activities of continuing operations:    
Depreciation and amortization 33.1 28.6
Equity in (earnings) loss of affiliates 0 0.3
Restructuring and other charges (income) 6.7 9.3
Deferred income taxes 1.3 15.2
Pension and other postretirement benefits 8.5 18.6
Share-based Compensation 3.8 5.2
Excess tax benefits from share-based compensation (3.4) (4.3)
Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:    
Trade receivables, net (82.2) (100.6)
Guarantees of vendor financing 28.9 (14.2)
Inventories (12.0) (4.6)
Other current assets and other assets (16.1) 6.3
Accounts payable (71.0) (55.5)
Accrued and other current liabilities and other liabilities 5.8 (10.3)
Advance payments from customers (148.4) (133.0)
Accrued payroll (29.0) (26.6)
Accrued customer rebates 86.2 120.3
Income taxes 9.3 2.5
Pension and other postretirement benefit contributions (23.8) (17.9)
Environmental spending, continuing, net of recoveries (1.6) (1.0)
Restructuring and other spending (1.9) (2.6)
Cash provided (required) by operating activities of continuing operations (85.3) (26.1)
Cash provided (required) by operating activities of discontinued operations:    
Environmental spending, discontinued, net of recoveries (3.7) (7.6)
Operating activities of discontinued operations of FMC Peroxygens (1.2) (2.5)
Payments of other discontinued reserves, net of recoveries (6.6) (8.3)
Cash provided (required) by operating activities of discontinued operations (11.5) (18.4)
Cash provided (required) by investing activities of continuing operations:    
Capital expenditures (75.3) (38.9)
Proceeds from disposal of property, plant and equipment 0 1.2
Acquisitions, net of cash acquired 0 (0.2)
Investments in nonconsolidated affiliates 0 (3.2)
Other investing activities (1.1) (5.5)
Cash provided (required) by investing activities of continuing operations (76.4) (46.6)
cash provided (required) by investing activities of discontinued operations [Abstract]    
Proceeds from FMC Peroxygens divestiture 199.1 0
Other discontinued investing activities 0.9 (8.6)
Cash provided (required) by investing activities of discontinued operations 200.0 (8.6)
Cash provided (required) by financing activities of continuing operations:    
Net borrowings (repayments) under committed credit facility 0 325.0
Increase (decrease) in short-term debt (39.6) (13.4)
Repayments of long-term debt (0.7) (0.3)
Proceeds from borrowings of long-term debt 0 0.4
Distributions to noncontrolling interests (3.0) (6.6)
Acquisition of noncontrolling interests 0 (72.0)
Issuances of common stock, net 5.2 2.9
Excess tax benefits from share-based compensation 3.4 4.3
Dividends paid (18.0) [1] (18.7) [1]
Repurchases of common stock under publicly announced program 0 (109.9)
Other repurchases of common stock (4.0) (6.4)
Cash provided (required) by financing activities of continuing operations (56.7) 105.3
Effect of exchange rate changes on cash and cash equivalents (0.8) (0.1)
Increase (decrease) in cash and cash equivalents (30.7) 5.5
Cash and cash equivalents, beginning of period 123.2 77.1
Cash and cash equivalents, end of period $ 92.5 $ 82.6
[1] See Note 13 regarding quarterly cash dividend